Abnormal Energy Homeostasis in ALS
Abnormal Energy Homeostasis in ALS
批准号:
7529077
负责人:
Robert G Kalb
金额:
$17.99万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2010-06-30
关键词:
AdipocytesAmyotrophic Lateral SclerosisAnimal FeedAnimalsBasal metabolic rateBehavioralBiochemicalDietDiseaseDisease ProgressionEatingEnergy IntakeEquationEquilibriumExpenditureFatty acid glycerol estersFoodHomeostasisHormonesHumanHyperphagiaInterventionLeptinLinkMeasuresMetabolicMetabolismMethodologyMonitorMotor Neuron DiseaseMotor NeuronsMusMuscleMutant Strains MiceNerve DegenerationNeurodegenerative DisordersNeuromuscular DiseasesNumbersObesityOrganismPatientsPharmacologyPhenotypePredispositionProcessProteinsPublic HealthRateSignal TransductionSuperoxide DismutaseSystemTimeTissuesTreatment ProtocolsWeight Gaindiet and exercisefeedingfood consumptiongenetic manipulationmetabolic abnormality assessmentmotor neuron degenerationmouse modelmutantpreventresearch studyrestorationtherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The longterm of objective of these studies is to determine if correcting the metabolic abnormalities in ALS will slow the progression of the neurodegeneration process. Specific aim - Previous studies of patients with ALS and mouse models of motor neuron disease have demonstrated an imbalance between energy intake and expenditure. The key abnormality is increased basal metabolic rate a problem evident in all tissue, most significantly in muscle. This imbalance of energy intake and expenditure is pathophysiologically significant, since it's partial correction by providing mutant mice with a high fat, high calorie diet slows disease progression. Specific aim: Is the motor neuron disease of mutant SOD mice prevented or slowed by genetically reducing basal metabolic rate? The Leptin-ObR signaling system controls food intake and basal metabolic rate. We will generate mice that express G93A mutant human SOD in the ob/ob background. The ob locus encodes the protein leptin and ob/ob mice are hypometabolic (among other metabolic derangements). We will monitor, over time, strength, endurance, survival, motor neuron number and metabolic parameters. Two dietary regimens will be studied: 1) Animals will be given ad libitum access to food and this leads to marked obesity in the ob/ob mice. The extent to which this will occur in mice expressing mutant in the ob/ob background can only be determined empirically as is the extent to which this influences motor neuron disease, 2) Animals will be pair-fed. The hypometabolic phenotype of the ob/ob leads to weight gain in pair fed animals, but less than occurs in animals with ad libitum access to food. This feeding paradigm isolates systemic hypometabolic alterations engendered by the ob/ob from the hyperphagia incurred by defective leptin-ObR signaling. Primary methodology/principle organism. We will use the G93A SOD mouse and the ob/ob mouse. Behavioral, anatomical, biochemical and metabolic studies will be undertaken. Relationship to neuromuscular disease. These studies are directly relevant to all motor neuron disease. PUBLIC HEALTH RELEVANCE: This project aims to link metabolism of the organism with susceptibility to neurodegenerative diseases. If food consumption and metabolic rate are related to neurodegenerative disease then new forms of intervention (i.e., diet, exercise, pharmacology) may prove useful therapeutically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
-
批准号:10552038
-
项目类别:
-
资助金额:$74.57万
-
财政年份:2022
-
负责人:Robert G Kalb
-
依托单位:
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
-
批准号:10342721
-
项目类别:
-
资助金额:$76.69万
-
财政年份:2022
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10406184
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10617853
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10274489
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9621133
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2018
-
负责人:Robert G Kalb
-
依托单位:
Cytohesins, ARF GTP'ases and Neurodegeneration
-
批准号:9605921
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2017
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9244083
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9114785
-
项目类别:
-
资助金额:$49.29万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
Cytohesins, ARF GTP'ases and Neurodegeneration
-
批准号:9275554
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
ERAD genes that suppress neurodegeneration
-
批准号:8821999
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2014
-
负责人:Robert G Kalb
-
依托单位:
Identification of the endogenous ligand of SAP97 PDZ3
-
批准号:8606782
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2013
-
负责人:Robert G Kalb
-
依托单位:
Identification of the endogenous ligand of SAP97 PDZ3
-
批准号:8507422
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2013
-
负责人:Robert G Kalb
-
依托单位:
Spatio-temporal control of FOXO3
-
批准号:8307681
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Spatio-temporal control of FOXO3
-
批准号:8445215
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Energy Balance and Neurodegenerative Disease
-
批准号:8371374
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Energy Balance and Neurodegenerative Disease
-
批准号:8465927
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Pathological retrograde signaling in ALS
-
批准号:7916362
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2009
-
负责人:Robert G Kalb
-
依托单位:
Trophic Factor Signaling and Motor Neuron Death
-
批准号:8787803
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2006
-
负责人:Robert G Kalb
-
依托单位:
Trophic Factor Signaling and Motor Neuron Death
-
批准号:8603291
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2006
-
负责人:Robert G Kalb
-
依托单位:
海外基金